IL155855A0 - Pharmaceutical formulation of gepirone for oral administration - Google Patents

Pharmaceutical formulation of gepirone for oral administration

Info

Publication number
IL155855A0
IL155855A0 IL15585501A IL15585501A IL155855A0 IL 155855 A0 IL155855 A0 IL 155855A0 IL 15585501 A IL15585501 A IL 15585501A IL 15585501 A IL15585501 A IL 15585501A IL 155855 A0 IL155855 A0 IL 155855A0
Authority
IL
Israel
Prior art keywords
gepirone
oral administration
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
IL15585501A
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL155855A0 publication Critical patent/IL155855A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
IL15585501A 2000-12-08 2001-11-30 Pharmaceutical formulation of gepirone for oral administration IL155855A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00204388 2000-12-08
PCT/EP2001/014189 WO2002045753A2 (en) 2000-12-08 2001-11-30 Oral extended release formulation of gepirone

Publications (1)

Publication Number Publication Date
IL155855A0 true IL155855A0 (en) 2003-12-23

Family

ID=8172397

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15585501A IL155855A0 (en) 2000-12-08 2001-11-30 Pharmaceutical formulation of gepirone for oral administration

Country Status (19)

Country Link
EP (1) EP1343504A2 (en)
JP (1) JP2004517083A (en)
KR (1) KR20040018314A (en)
CN (1) CN1479620A (en)
AR (1) AR031461A1 (en)
AU (1) AU2002226371A1 (en)
BR (1) BR0115976A (en)
CA (1) CA2436692A1 (en)
CZ (1) CZ20031589A3 (en)
EC (1) ECSP034627A (en)
HU (1) HUP0401021A2 (en)
IL (1) IL155855A0 (en)
MX (1) MXPA03005099A (en)
NO (1) NO20032581D0 (en)
PL (1) PL362445A1 (en)
RU (1) RU2003120446A (en)
SK (1) SK6942003A3 (en)
WO (1) WO2002045753A2 (en)
ZA (1) ZA200303915B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1545469A1 (en) * 2002-09-24 2005-06-29 Akzo Nobel N.V. Method to improve pharmaceutical tablets having a matrix of cellulose ether
BRPI0419179A (en) * 2004-11-05 2007-12-18 Fabre Kramer Pharmaceuticals I high dosage prolonged release formulation of gepirone
US20200205456A1 (en) * 2017-07-26 2020-07-02 Abbott Laboratories Nutritional tablets and methods of making the same
CN109745323A (en) * 2017-11-01 2019-05-14 四川科瑞德制药股份有限公司 Azapirone compound improves the active purposes of parasympathetic nerve

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form

Also Published As

Publication number Publication date
SK6942003A3 (en) 2003-10-07
CA2436692A1 (en) 2002-06-13
PL362445A1 (en) 2004-11-02
WO2002045753A2 (en) 2002-06-13
CN1479620A (en) 2004-03-03
ECSP034627A (en) 2004-09-28
JP2004517083A (en) 2004-06-10
NO20032581L (en) 2003-06-06
ZA200303915B (en) 2004-08-20
MXPA03005099A (en) 2004-02-12
EP1343504A2 (en) 2003-09-17
BR0115976A (en) 2003-12-30
AU2002226371A1 (en) 2002-06-18
NO20032581D0 (en) 2003-06-06
WO2002045753A3 (en) 2002-08-29
AR031461A1 (en) 2003-09-24
HUP0401021A2 (en) 2004-09-28
RU2003120446A (en) 2005-02-20
KR20040018314A (en) 2004-03-03
CZ20031589A3 (en) 2003-11-12

Similar Documents

Publication Publication Date Title
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
PL356358A1 (en) Solid dosage form of someticone for oral administration
PL368636A1 (en) Pharmaceutical dosage forms of epothilones for oral administration
AU2002216701A1 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
HUP0301921A3 (en) Sustained release pharmaceutical compositions for paranteral administration of hydrophilic compounds
IL166489A (en) Two-layerd oral dosage form for once-a-day administration of paliperidone and uses thereof
EG23943A (en) Flash-melt oral dosage formulation
AU2001283563A1 (en) Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
AU2002357012A1 (en) Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
AU2001230892A1 (en) Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same
PL342988A1 (en) Novel galenic formulations of meloxicam for oral administration
HUP0202495A3 (en) Stable medicinal compositions for oral use
IL145559A0 (en) Tolperison-containing pharmaceutical preparation for oral administration
GB2355656B (en) Pharmaceutical compositions for oral and topical administration
HUP0201667A3 (en) Oral form of administration
IL155855A0 (en) Pharmaceutical formulation of gepirone for oral administration
GB0201607D0 (en) Formulation for the administration of medicinal substances
EP1188440A4 (en) Medicinal composition for oral administration
EP1352652A4 (en) Fat composition for oral or enteral administration and hexacosanoic acid depressant
GB0014474D0 (en) Pharmaceutical formulation and manufacture of oral dosage units
HU0303147D0 (en) Pharmaceutical compositions for oral and topical administration
AU2002317063A (en) Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
AU2002301781A1 (en) Solid pharmaceutical compositions for oral administration comprising itraconazole
AU2002317063A1 (en) Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
GB0030587D0 (en) Oral administration of beneficial substances